Weekly Recap | Tempus AI +31.91%, closing in on record highs
I'm LongbridgeAI, I can summarize articles.Tempus AI (TEM) rallied 31.91% this week to close at $77.84, against the S&P 500’s -0.08%, outperforming the benchmark by roughly 31.99 percentage points. It was not a straight-line climb: Monday (Sep 14) opened around $57.725 and closed at $62.21, followed by steady gains on Tuesday and Wednesday. Thursday surged intraday to $81.28, and Friday opened near $81.40 before pulling back to settle at $77.84. Weekly amplitude hit 41.77%, with a wide high-low range and heavier trading volume.
The Week
Tempus AI (TEM) rallied 31.91% this week to close at $77.84, against the S&P 500’s -0.08%, outperforming the benchmark by roughly 31.99 percentage points. It was not a straight-line climb: Monday (Sep 14) opened around $57.725 and closed at $62.21, followed by steady gains on Tuesday and Wednesday. Thursday surged intraday to $81.28, and Friday opened near $81.40 before pulling back to settle at $77.84. Weekly amplitude hit 41.77%, with a wide high-low range and heavier trading volume.
Key Events
The week’s narrative centred on Tempus AI’s own fundamental progress and a strong run in market sentiment. Early in the week, the founder publicly backed Anthropic CEO’s call to slow AI model development, drawing attention across the AI healthcare space. News around the company’s whole genome research platform continued to build, and a 7.35% single-day gain on Sep 15 helped fuel optimism about revenue growth. On Thursday, the founder highlighted growth signals again, driving an intraday jump of more than 13% and extreme moves in some call options. After Friday’s close, data showed data licensing volume expansion and the company’s first profitable quarter, providing support for the rally into the weekend. The same day also brought small share disposals by the CEO and an executive, though in size they looked more like routine selling.
Analyst Ratings
As of Sep 17, 19 institutions covered TEM: 8 rate it buy, 2 overweight, 8 hold, and 1 sell. In total, 10 give buy or overweight ratings, while 1 gives a sell rating. The consensus rating is buy, with a consensus target price of $68.18, about -12.41% versus the current price of $77.84. The target range is wide, from $35 to $100, reflecting material disagreement. Within life sciences tools and services, Tempus AI ranks 9th out of 54 companies.
The Week Ahead
The week ahead is mostly about macro and liquidity data. Tuesday (Sep 22) brings the U.S. Richmond Fed composite index, with a prior reading of 4; Wednesday (Sep 23) has EIA weekly crude oil inventories and Cushing inventories; Thursday (Sep 24) is busiest, with initial jobless claims, the current account balance, new home sales annualised, and EIA natural gas storage. Initial jobless claims came in at 196 previously, and new home sales have a forecast of 0.608. After Friday’s pullback and post-close profit news, whether the market extends that follow-through into next week will be a key watch.
In Short
This week, Tempus AI showed a mix of sentiment and fundamental tailwinds colliding with widening valuation disagreement. Most brokers rate it buy or overweight, and the consensus rating is positive; at the same time, the consensus target of $68.18 sits below spot, with targets ranging from $35 to $100. Negative P/E and a roughly 31.39x P/B mean conventional value anchors offer little footing. On the latest trading day, small-lot money was the larger net seller while large-lot money turned net buyer. The key forward question is whether the data licensing expansion and first profitable quarter can keep getting validated next week.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
